By pathway analysis, they suggested that a downregulation of C1orf132 was associated with a poor prognosis in lung cancer patients, probably by deregulating the “cell cycle and cell adhesion molecules” pathways in cancer cells [41]. Here, MIR29B2CHG is linked to lung carcinoma.